|
| |
| | 68441 | | 09.06.2022 | | Novartis Pharma Schweiz AG | | | | | | 08.06.2027 | | | | | | 07.16.10. | | | | 07.16. | | IP |
| Seq.-No. | Product | Description | Galenic form | ATC-classification | |
---|
01 | Scemblix 20 mg | Filmtabletten | Coated tablets (Asciminibum 20 mg) | L01EA06 | CI | 02 | Scemblix 40 mg | Filmtabletten | Coated tablets (Asciminibum 40 mg) | L01EA06 | |
|
|
|